Micregen Ltd

Overview

Legal name

MICREGEN LTD

Region

North West England

Registered address

FOURTH FLOOR

UNIT 5B THE PARKLANDS

BOLTON

UNITED KINGDOM

BL6 4SD

Insolvency history

Corporate ownership

Updated 06 Jun 2026 16:52

Controls 2

Micregen Ltd

No active corporate controller recorded.

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS

Turnover

Unknown

Profit / Loss

Unknown

Employees

Company events

Reference milestones and recent Companies House filing stream events.

9 events

30 Sep

2026

Accounts due

Accounts Due

Next accounts due date

24 Aug

2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

10 Aug

2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec

2024

Accounts filed

Accounts

Last accounts made up date

09 Sep

2024

Second Filing Of Confirmation Statement With Made Up Date

Confirmation-statement

RP04CS01 | Transaction MzQzNDkyNzA2MmFkaXF6a2N4 | Paper/PDF filed

Published 11 Sep 2024 06:00

27 Aug

2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQzMzQ3NjI0MWFkaXF6a2N4

Published 27 Aug 2024 14:23

21 Aug

2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzMjk1MjM4NWFkaXF6a2N4

Published 21 Aug 2024 14:40

10 Aug

2022

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzM0ODMzMjc4OWFkaXF6a2N4 | Paper/PDF filed

Published 10 Sep 2024 06:08

03 Aug

2015

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2018

Funded years

2018

Age at first award

2 years

Projects

2018 Feasibility Studies Lead participant

MICREGEN – A novel therapeutic for treating necrotising enterocolitis (NEC)

1 Feb 2018 to 28 Feb 2019

Awarded

£373,680

Total cost £533,828

Awaiting clarity on public summary

Product types

Feasibility Studies